tm
Seeing Is Believing
tm
Seeing Is Believing
APLS is currently covered by 20 analysts with an average price target of $41.01. This is a potential upside of $14.1 (52.4%) from yesterday's end of day stock price of $26.91.
Apellis Pharmaceuticals's activity chart (see below) currently has 260 price targets and 287 ratings on display. The stock rating distribution of APLS is 38.1% HOLD and 61.9% BUY.
Analysts average stock forecasts to be materialized ratio is 64.4% with an average time for these price targets to be met of 187.32 days.
Highest price target for APLS is $57, Lowest price target is $18, average price target is $42.42.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 29-Jul-2025. First documented stock forecast 04-Dec-2017.
Currently out of the existing stock ratings of APLS, 48 are a HOLD (38.1%), 78 are a BUY (61.9%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$46
$17.87 (63.53%)
$41
1 months 9 days ago
(29-Jul-2025)
20/26 (76.92%)
$27.05 (142.74%)
216
Hold
$24
$-4.13 (-14.68%)
$23
1 months 22 days ago
(16-Jul-2025)
5/10 (50%)
$4.25 (21.52%)
29
Hold
$29
$0.87 (3.09%)
$26
3 months 5 days ago
(02-Jun-2025)
9/13 (69.23%)
$9.86 (51.52%)
110
Hold
$20
$-8.13 (-28.90%)
$30
3 months 24 days ago
(14-May-2025)
5/11 (45.45%)
$3.3 (19.76%)
60
Buy
$52
$23.87 (84.86%)
$106
3 months 29 days ago
(09-May-2025)
2/17 (11.76%)
$34.7 (200.58%)
570
What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on APLS (Apellis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?
Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?
